Change in optic nerve conduction velocity (NCV) at Week 24 for the affected eye from the baseline of unaffected fellow eye as determined by full-field visual evoked potential (FF-VEP). 24 weeks [clinicaltrials_resource:a505fb360e70e75124b8dfb0c3f53472]
One pre-dose PK sample and 1 post-dose PK sample (approximately between 1 and 3 hours after the end of IV infusion) will be collected for ALL participants on Day 1 and at Weeks 4 through 20 (every 4 weeks). Additionally, only 1 PK sample will be collected at Week 24 and Week 32.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change in optic nerve conduction velocity (NCV) at Week 24 for the affected eye from the baseline of unaffected fellow eye as determined by full-field visual evoked potential (FF-VEP). 24 weeks [clinicaltrials_resource:a505fb360e70e75124b8dfb0c3f53472]
One pre-dose PK sample and 1 post-dose PK sample (approximately between 1 and 3 hours after the end of IV infusion) will be collected for ALL participants on Day 1 and at Weeks 4 through 20 (every 4 weeks). Additionally, only 1 PK sample will be collected at Week 24 and Week 32.
Bio2RDF identifier
a505fb360e70e75124b8dfb0c3f53472
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a505fb360e70e75124b8dfb0c3f53472
measure [clinicaltrials_vocabulary:measure]
Change in optic nerve conducti ...... ual evoked potential (FF-VEP).
time frame [clinicaltrials_vocabulary:time-frame]
description
One pre-dose PK sample and 1 p ...... lected at Week 24 and Week 32.
identifier
clinicaltrials_resource:a505fb360e70e75124b8dfb0c3f53472
title
Change in optic nerve conducti ...... d potential (FF-VEP). 24 weeks
@en
type
label
Change in optic nerve conducti ...... 5fb360e70e75124b8dfb0c3f53472]
@en